TW200640870A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
TW200640870A
TW200640870A TW095106174A TW95106174A TW200640870A TW 200640870 A TW200640870 A TW 200640870A TW 095106174 A TW095106174 A TW 095106174A TW 95106174 A TW95106174 A TW 95106174A TW 200640870 A TW200640870 A TW 200640870A
Authority
TW
Taiwan
Prior art keywords
novel compounds
formula
pharmaceutically acceptable
provided according
acceptable solvates
Prior art date
Application number
TW095106174A
Other languages
Chinese (zh)
Inventor
Tracy Jane Shipley
Anne Jones
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of TW200640870A publication Critical patent/TW200640870A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

There is provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable solvates thereof:
TW095106174A 2005-02-25 2006-02-23 Novel compounds TW200640870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0503955.7A GB0503955D0 (en) 2005-02-25 2005-02-25 Novel compounds

Publications (1)

Publication Number Publication Date
TW200640870A true TW200640870A (en) 2006-12-01

Family

ID=34430239

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095106174A TW200640870A (en) 2005-02-25 2006-02-23 Novel compounds

Country Status (5)

Country Link
AR (1) AR052488A1 (en)
GB (1) GB0503955D0 (en)
PE (1) PE20061229A1 (en)
TW (1) TW200640870A (en)
WO (1) WO2006089689A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012513464A (en) * 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク Phosphodiesterase inhibitors and uses thereof
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
EP2569285A1 (en) 2010-05-10 2013-03-20 Gilead Sciences, Inc. Bifunctional quinoline derivatives
CN103508950B (en) * 2012-06-25 2016-04-20 南开大学 Containing 4-hydroxyl-2-quinolinones compound and the Synthesis and applications thereof of imine structure
CA2900302C (en) 2013-02-19 2018-07-03 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
JP6713982B2 (en) 2014-07-24 2020-06-24 ファイザー・インク Pyrazolopyrimidine compounds
JP6506833B2 (en) 2014-08-06 2019-04-24 ファイザー・インク Imidazopyridazine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912519A1 (en) * 1996-05-20 1999-05-06 Darwin Discovery Limited Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
PE20061229A1 (en) 2006-12-04
AR052488A1 (en) 2007-03-21
GB0503955D0 (en) 2005-04-06
WO2006089689A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
JO2947B1 (en) Cyclopamine Analogs
TW200503724A (en) Novel pharmaceuticals
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
CY1109911T1 (en) PYRROLOVENZODIAZEPINES
MY151003A (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
PT1761520E (en) Kinase inhibitors
GB0127903D0 (en) Improvements relating to organic compounds
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
SG171617A1 (en) Therapeutic compounds
MX2007005694A (en) Novel betulin derivatives, preparation thereof and use thereof.
TW200728307A (en) Novel spirochromanone derivatives
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
MXPA05009969A (en) Methods for isolating crystalline form i of 5-azacytidine.
MY143516A (en) Kinase inhibitors
TW200640870A (en) Novel compounds
TNSN08244A1 (en) Process for the preparation of ferri-succinylcasein
EA200801366A1 (en) DERIVATIVES 3,6-DIGIDRO-2-OXO-6N-1,3,4-TIADIAZINA
WO2007082262A3 (en) Novel compounds
DE602004012146D1 (en) Pyrazolopyrimidine
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols